Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8337850 4-1BB binding molecules

Patent 8337850 was granted and assigned to Pfizer Limited on December, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Libbey Anne Yates0

Bianca Ahrens0

Kathrin Ladetzki-Baehs0

Leslie Lynne Sharp0

Michael Tesar0

Moritz Zulley0

Richard Michael Jerome0

Sangita M. Baxi0

...

Date of Patent

December 25, 2012

0

Patent Application Number

132285320

Date Filed

September 9, 2011

0

Patent Citations Received

US Patent 11866688 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

0

US Patent 11942149 Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof

0

US Patent 11964978 Modulators of STING (stimulator of interferon genes)

0

US Patent 11981921 TIL expansion processes using specific cytokine combinations and/or AKTi treatment

0

US Patent 11999800 Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer

0

US Patent 11680090 Interleukin-2 fusion proteins and uses thereof

0

US Patent 11713446 Processes for generating TIL products enriched for tumor antigen-specific T-cells

0

US Patent 11752207 Agonist antibodies that bind human CD137 and uses thereof

...

Patent Primary Examiner

Bridget E Bunner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8337850 4-1BB binding molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool